A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

Clinical trial NCT06525935 · COMPLETED

Trial details

NCT number: NCT06525935
Sponsor: Carmot Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity Overweight

Start date: 2024-08-16
Primary completion: 2025-12-08
Enrollment: 469

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.